Incidence of Endocrine and Exocrine Pancreatic Insufficiency after Minimally Invasive Parenchyma-Sparing Pancreatectomy.

Solinas D, Dal Molin M, Campbell BA, Zhang S, Cameron JL, Shubert CR, Lafaro KJ, Burkhart RA, Burns WR, He J

Pancreatic and Peripancreatic Neural Crest-Derived Tumors: An Updated Contemporary Single Center Experience.

Shamoun F, Ghabi EM, Thompson ED, Cameron JL, Shubert CR, Lafaro KJ, Burkhart RA, Burns WR, He J

Incidental Diagnosis of Pancreatic Cancer and Association with Improved Patient Outcomes: Assessing the Potential Clinical Use of Liquid Biopsy-Based Screening Tests.

Javed AA, Habib JR, Fishman EK, Cameron JL, Hruban RH, Wolfgang CL, He J

Disrupted maternal care alters neural-microglia interactions in the primate paralaminar (PL) nucleus of the amygdala.

King DP, Khan M, Majewska AK, Cameron JL, Fudge JL

Management and outcomes for portal venous thrombosis after pancreaticoduodenectomy.

Sattari SA, Campbell BA, Zhang S, McPhaul T, Liddell RP, Shubert CR, Burns WR, Burkhart RA, Lafaro K, Cameron JL, He J

The impact of perioperative chemotherapy in patients with pancreatic adenosquamous carcinoma.

Campbell BA, Habib JR, Kinny-Köster B, Purchla J, Franco JC, Putri AJ, Sahni S, Hewitt DB, Sacks GD, Shubert CR, Lafaro KJ, Burkhart RA, Burns WR, Thompson ED, Kaiser J, Javed AA, Cameron JL, Loos M, Wolfgang CL, Büchler MW, He J

The Mutational Status of Driver Genes in Patients With Resected Pancreatic Ductal Adenocarcinoma Is Associated With Pathological Characteristics and Overall Survival.

Campbell BA, Solinas D, Blackford AL, Dal Molin M, Purchla J, McPhaul T, Chidambaram S, Cameron JL, Lin MT, Hruban RH, Shubert CR, Lafaro KJ, Burkhart RA, Burns WR, He J

Association Between Adjuvant Therapy and Survival in Resected Pancreatic Ductal Adenocarcinoma After Different Types and Durations of Neoadjuvant Therapy.

Andel PCM, Campbell BA, Habib JR, Molenaar IQ, Lafaro KJ, Burns WR 3rd, Daamen LA, Cameron JL, Wolfgang CL, Burkhart RA, He J, Javed AA

Prognostic Features in Surgically Resected Well-Differentiated Pancreatic Neuroendocrine Tumors: an Analysis of 904 Patients with 7882 Person-Years of Follow-Up.

Kiemen AL, Young ED, Blackford AL, Wu P, Burkhart RA, Burns WR, Cameron JL, Lafaro K, Shubert C, Gaillard Z, Ebong UA, Reucroft I, Shen Y, Dequiedt L, Matos V, Klöppel G, Kasajima A, He J, Hruban RH

ASO Visual Abstract: Association Between Adjuvant Therapy and Survival in Resected Pancreatic Ductal Adenocarcinoma After Different Types and Durations of Neoadjuvant Therapy.

Andel PCM, Campbell BA, Habib JR, Molenaar IQ, Lafaro KJ, Burns WR 3rd, Daamen LA, Cameron JL, Wolfgang CL, Burkhart RA, He J, Javed AA